Alkido Pharma Inc (AIKI) News

Got it thanks!

Hi, I haven't been following AIKI for a while, just noticed its not trading, checked TDA / google with no result, did the ticker change or not public anymore after company bought shares? Thanks!

More insider shares purchased today…

More insider shares purchased…

AIKI looks to be headed back to 7…

More insider shares purchased…

A positive week… up 3.11%

…more shares purchased by the CEO

…AIKI seems to be getting its legs

AIKI is undervalued…

AIKI is ready…

The Company reported that on October 5, 2022, the Company purchased 10,500 shares of common stock at $7.0679 per share.

The Company reported that on October 4, 2022, the Company purchased 38,035 shares of common stock at $6.99 per share. Anthony Hayes, CEO of AIkido stated, "We believe the Company stock continues to be undervalued and we are using this opportunity to enhance shareholder value by reducing the amount of stock that is outstanding."

AIKI is buying more shares… 45k

Shalom Auerbach board member on AMRR doesn’t mess around.



Shalom Auerbach, a significant stockholder of AIkido Pharma Inc. (NASDAQ: AIKI) beneficially owning approximately 3.4% of its common stock, today issued the following letter to members of the AIkido Pharma Inc. Board of Directors:

https://www.streetinsider.com/dr/news.php?id=20187179&gfv=1

https://www.prnewswire.com/news-releases/aikido-pharma-secures-interest-in-electric-truck-maker-tevva-motors-ltd-301386841.html

Averaging in some .48s

Snagging some 50s

AIkido Pharma announces $3M share repurchase program

https://ih.advfn.com/stock-market/NASDAQ/alkido-pharma-AIKI/stock-news/87087386/aikido-pharma-announces-3m-share-repurchase-progr

Classic dog pile here. I'm out and won't be back.

AIKI .47 - So, outsiders have sold this company's stock down to less than .50-on-the-dollar and insiders aren't filing Form-4-Buys by the truckload? How can management EVER promote it's own stock again when they show no interest in less than .50-on-the-dollar?

And what would be management's risk be in buying here at less than .50-on-the-dollar? It goes down to .25-on-the-dollar...whoa-is-me

One of the worst companies I've invested in. Finally dumped it for big loss. I obviously played the fool again. Glta

AIKI...72...:partying_face:

Get ready for the buttered popcorn...

AIKI...73...Bullish 3 Gap Downs Reversal Pattern to the Upside on this Oversold Chart...

Psar flipped Bullish...Been accumulating under $1...

Chart https://schrts.co/exhPMSRA ...

Looks like good news AlKl

https://apple.news/AnumIdrGsR-CRYxMFTxj-5Q

This should go over a dollar soon here!!!!

AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI

AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI— Tommy Coops (@ohheytommy) October 12, 2021

AIKI...92...on the P/M Gappa...:partying_face:

Impressed with the CEO management taking investment stakes in pivotal companies, thereby adding significant value here. Great job IMO.

Interesting, low ss here...

Very volatile but looks ready

Added let’s see what this can do

Kaboom!

Bullish

Would be nice... it has been ages since they did the financing around $1.65 and it began to drop ever since

AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching

News...

AIKI...86...Tue, July 27, 2021, 10:00 AM
AIkido's License to Technology Includes Targeted Psilocybin Treatment for Cancer Patients

NEW YORK, July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/477,125. This technology relates to the use of novel and proprietary central nervous system (CNS) homing peptides. This technology has been exclusively sublicensed to AIkido Pharma for use of psilocybin for the therapeutic treatment of neuroinflammatory disease in cancer patients.

AIKI...97...Bounce off the .85 range on the Bullish Engulfing Reversal Candle to the Upside...

Psar flipped to a Bullish Buy Position...as the MACD Crossed to the positive side...

Chart...https://schrts.co/FqVVQIHY ...

$1.10 nice

No respect from the street on this company. Corporate..how about getting some dignity and respect by actually executing and aggressive communications to the investing arena? Grow a pair..

Yeah definitely under substantial book value here. Not just on cash, but potential pipeline, nols, licensing rev's. You buy the dips here and wait on a significant return.

BULLISH RESEARCH ARTICLE! Trading under cash and great upside on great results. https://insiderfinancial.com/akido-pharmas-aiki-clinical-trial-results-continues-to-validates-gileads-21-billion-purchase-of-immunomedics/181580/

* * $AIKI Video Chart 04-21-2021 * *

Link to Video - click here to watch the technical chart video

AIKI...86...NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conducted by a leading global pharmaceutical company. The report provides strong indications for analogous success in similar technology the Company is helping to develop.

The article can be accessed at:
https://www.thepharmaletter.com/article/further-vindication-for-novartis-in-radioligand-space

AIKI...$1.20...in the P/M...NEW YORK, April 7, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of novel and proprietary central nervous system (CNS) homing peptides for the therapeutic treatment of neuroinflammatory disease in cancer patients...

https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1857821

AIKI...$1.17...Bidding the Lower Band to the 20ma to add to my Core Position...

Looking for the 2 Open Gaps to fill and a $2 Breakout..imo...we shall see....

Chart...https://schrts.co/BrjKBXYy ...

AIKI...$1.17...in the P/M...https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1849940 ...:party:

$aiki $1.17 ? 0.0 (0.00%)
Volume: 3,920,435 @03/26/21 7:41:58 PM EDT

* * $AIKI Video Chart 03-24-2021 * *

Link to Video - click here to watch the technical chart video